Aura Biosciences (AURA) Retained Earnings (2020 - 2026)
Aura Biosciences (AURA) posted Retained Earnings of -$514.1 million for Q1 2026, down 7.01% on a QoQ basis from -$480.4 million in Q4 2025, and down 27.98% year-over-year from -$713.8 million in Q1 2025.
Aura Biosciences (AURA) Retained Earnings (2020 - 2026) Analysis & Trends
Aura Biosciences' Retained Earnings history runs 7 years deep, the most recent figure standing at -$514.1 million for Q1 2026.
- Quarterly Retained Earnings fell 27.98% year-over-year to -$514.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$514.1 million (down 27.98% YoY) and the FY2025 annual result came in at -$480.4 million, down 28.38% from the prior year.
- Retained Earnings was -$514.1 million for Q1 2026 at Aura Biosciences, down from -$480.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $611.5 million in Q3 2025 and bottomed at -$514.1 million in Q1 2026.
- A 5-year average of $14.3 million and a median of -$147000.0 in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 323010.16% in 2023, while the deepest fall reached 180292.52% in 2023.
- Aura Biosciences' Retained Earnings stood at $406.6 million in 2022, then rose by 26.09% to $512.6 million in 2023, then tumbled by 173.0% to -$374.2 million in 2024, then decreased by 28.38% to -$480.4 million in 2025, then declined by 7.01% to -$514.1 million in 2026.
- Business Quant data shows AURA's Retained Earnings at -$514.1 million in Q1 2026, -$480.4 million in Q4 2025, and $611.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -514.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -514.10 Mn |
| Dec 31, 2025 | -480.42 Mn |
| Sep 30, 2025 | 611.46 Mn |
| Jun 30, 2025 | 603.33 Mn |
| Mar 31, 2025 | -401.71 Mn |
| Dec 31, 2024 | -374.23 Mn |
| Sep 30, 2024 | -348.39 Mn |
| Jun 30, 2024 | -327.35 Mn |
| Mar 31, 2024 | -307.01 Mn |
| Dec 31, 2023 | 512.62 Mn |
| Sep 30, 2023 | -265.18 Mn |
| Jun 30, 2023 | 413.33 Mn |
| Mar 31, 2023 | 408.67 Mn |
| Dec 31, 2022 | 406.56 Mn |
| Sep 30, 2022 | -147,000.00 |
| Jun 30, 2022 | -128,000.00 |
| Mar 31, 2022 | 306.06 Mn |
| Dec 31, 2021 | -152.14 Mn |
| Sep 30, 2021 | -140.50 Mn |
| Dec 31, 2020 | -116.89 Mn |